FC GAMMA RECEPTOR MUTATIONS FOR PREDICTION OF SUSTAINED CLINICAL REMISSION AFTER INFLIXIMAB DISCONTINUATION IN CROHN’S DISEASE PATIENTS

(1) Ku Leuven, Department Of Clinical And Experimental Medicine And University Hospitals Leuven, Department Of Gastroenterology, Leuven, Belgium



This item was part of the Old and new biomarkers in IBD session at UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)